System Transmission

Top Signal

100#1 JOB

Activity

2162Ripe

+919 today

System

Livenow

Terminal Asset View

stockNASDAQ

EDIT

$2.44-3.94%

Editas Medicine Inc. - Common Stock

Overripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

23Overripe

Live Analysis Active

Company Mission

Editas Medicine develops gene-editing treatments for genetic diseases like sickle cell anemia and certain eye conditions. The company uses CRISPR technology to modify DNA in patients' cells, aiming to correct genetic defects that cause illnesses. It makes money through research partnerships with pharmaceutical companies and could earn revenue from future drug sales if its treatments receive regulatory approval.

EDI

Industry Context

The biotechnology industry focuses on developing medical treatments using biological systems. Gene-editing companies like Editas are part of a cutting-edge segment that creates therapies by modifying DNA to treat genetic conditions. This sector experiences significant price swings based on clinical trial results, regulatory approvals, and investor sentiment toward scientific breakthroughs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

29Matrix

Market Momentum

69.7— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

-3.94%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing EDIT across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 05:33 PM UTC

As-of 03-14-2026 17:17 UTC

Develops gene-editing treatments for genetic diseases and makes money by partnering with drug companies to advance these therapies.

Weekly volatility is tightening, suggesting energy is building for a larger move when the consolidation breaks.

Volume sits at ninety-one percent of its recent average, suggesting normal trading activity that confirms the balanced momentum reading of forty-five showing support pattern.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...